Navigation Links
Excellence in Scientific Innovation and Humanitarian Efforts Honored at 2011 Prix Galien Award Ceremony
Date:9/28/2011

NEW YORK, Sept. 28, 2011 /PRNewswire/ -- The Prix Galien USA committee recognized excellence in scientific innovation that improves the state of human health last night during the fifth annual Prix Galien Awards Gala. The Pro Bono Humanum Award and the Prix Galien USA 2011 Awards for best biotechnology product and best pharmaceutical agent were presented at a ceremony held at the Museum of Natural History in New York City.  

The Prix Galien USA 2011 Award selection committee is an unrivaled network that includes seven Nobel Laureates in medicine and is led by Peace Prize winner, Professor Elie Wiesel.  This year the committee honored Dr. Paul Farmer as the recipient of the 2011 Pro Bono Humanum award for his lifetime of humanitarian efforts in Haiti and throughout the world, while also advancing the fight against infectious diseases, including AIDS and tuberculosis.  

"Dr. Farmer is an exemplary model of how one person can be a catalyst between science, business and government to serve as a beacon of hope to those in need," said Mr. Wiesel. "Dr. Farmer's dedication to combating deadly diseases while fighting poverty and inequality in developing countries is inspirational."

In recognition of the development and discovery of biotechnology products that improve the human condition, the selection committee awarded Janssen Biotech, Inc.'s Stelara® and Amgen's Prolia® each with the 2011 Prix Galien USA Award for Best Biotechnology Product.  Stelara®, from Janssen Biotech, Inc., is a treatment for plaque psoriasis that may help provide clearer skin and relief from symptoms, including plaque thickness, scaling, and redness. Amgen's Prolia® is the first and only prescription therapy for postmenopausal osteoporosis that is given as one shot every six months in a doctor's office.

For pharmaceutical advancements, the 2011 Prix Galien USA Award for Best Pharmaceutical Agent was awarded to Pfizer's Prevnar 13®, a pediatric vaccine that helps protect against 13 strains of pneumococcal bacteria.

"The development of these innovative solutions will inform future developments in the fields of biotechnology and pharmaceuticals for years to come," said Gerald Weissmann, M.D., Prix Galien USA committee chair, Research Professor of Medicine at NYU and editor-in-chief of The FASEB Journal. "It is our honor to recognize and award the technical, scientific and clinical research skills that contributed to the development of the products that received the 2011 Prix Galien Awards."

Support for the Prix Galien Awards is provided by Oracle, DDB Healthcare, Proskauer, Cross River Bank, Deloitte, Alexandria Real Estate, Only Lyon, Medidata, Porter Novelli and SAS.

The Prix Galien Award recognizes, and is considered the industry's highest accolade, equivalent to the Nobel Prize. Prix Galien was first established in 1970 by French pharmacist Roland Mehl and was inaugurated in the United States in September 2007.

For details about the Prix Galien USA award and committee, visit www.galienfoundation.org.

CONTACT:
Mary Heather
Porter Novelli for Prix Galien USA
+1-212-601-8153
Mary.Heather@porternovelli.com


'/>"/>
SOURCE Prix Galien USA
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. STAR Cranial Centers of Excellence Offer Cutting-Edge Treatment to Dallas Area Children
2. Elektas New Line of Stereotactic Treatment Solutions is Redefining Excellence in Stereotaxy, a Case at a Time
3. American College of Cardiology and Center of Excellence for Simulation Research of Western Michigan University (CESR) Partner for in situ Simulation to Improve Team Communication and Door-to-Balloon (D2B) Time
4. PEAK Surgical Announces Completion of First PRECISE Clinical Study, Receipt of Medical Design Excellence Award for PEAK(R) Surgery System and Achievement of Over 1,000 Surgeries Using PEAK PlasmaBlade(TM)
5. Malaria Vaccine Developer, Sanaria Inc., Receives 2009 Vaccine Industry Excellence Award for Best Early-Stage Vaccine Biotech
6. Roche Scientist Recognized for Excellence in Peptide Chemistry
7. National Intrepid Center of Excellence To Combat Traumatic Brain Injury With Sophisticated Brain Mapping Technology From Elekta
8. Ikaria Receives Award for Excellence by New Jersey Business & Industry Association
9. Call for Applications: The Amgen Award for Science Teaching Excellence
10. Giant Eagle(R) Pharmacy Receives Award for Operational Excellence
11. Zimmer Natural Knee Celebrates 25 Years of Excellence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... , January 17, 2017 ... to potentially earn millions in revenue with the planned ... massive numbers of strokes with a simple test that ... Companies with latest developments in the markets today include: ... (NYSE: AZN ), Cancer Genetics, Inc. (NASDAQ: ...
(Date:1/17/2017)... 17, 2017 Catherine ... http://www.touchneurology.com/articles/tailored-temperature-management-neurocritical-care ...      (Logo: ... European Neurological Review , ... Amey reports that despite standard care, temperatures ...
(Date:1/17/2017)... 17, 2017  The pioneer in no-touch UV disinfection has ... Tru-D SmartUVC , short for "total room ultraviolet disinfection," was ... Terminal Room-Disinfection (BETR-D) study which was recently published in ... that Tru-D can cut transmission of four major superbugs by ... to market in 2007, we have been committed to innovation ...
Breaking Medicine Technology:
(Date:1/16/2017)... ... January 16, 2017 , ... Etymotic Research, ... GunSport•PRO® and EB15•LE® electronic earplugs at the NSSF SHOT Show on January 17-20, ... The SHOT Show is the shooting, hunting and outdoor trade show and conference ...
(Date:1/16/2017)... ... 16, 2017 , ... As New York’s fastest growing ophthalmic ... to their medical staff, according to eye surgeon, Jeffrey Martin, MD, FACS, Chief ... division of SightMD. Dr. Giamos will practice primarily out of SightMD’s Riverhead, Southampton, ...
(Date:1/16/2017)... ... ... are well-aware of the following facts at present:, Flu and ... no effect on keeping this particularly bad strain of the flu away , ... sniffling , These facts are well-known among the team at Woodard! About ...
(Date:1/16/2017)... (PRWEB) , ... January 16, 2017 , ... One thing ... only to treat, but to test for, as well. The money spent screening for ... year.(1) Doctors in the U.S. screen patients for cancer more than in any other ...
(Date:1/15/2017)... ... , ... In this role, Courtney will be responsible for developing new business ... friendly mark. This certification program was created by ASL and the nonprofit Asthma and ... suitable for the 60+ million people living in the U.S. with asthma and allergies. ...
Breaking Medicine News(10 mins):